Tag: Therapeutics
CRISPR Therapeutics Poised for Growth as FDA Eases Gene Editing Approvals
The FDA's plan to streamline gene editing therapy approvals could accelerate CRISPR Therapeutics' growth and attract investment by reducing regulatory…
CRISPR Therapeutics Advances With Promising CTX460 Results
CRISPR Therapeutics recently reported promising preclinical results for CTX460, demonstrating strong gene correction in animal models, which has boosted investor…
Crispr Therapeutics AG Announces $600M Share Offering for Innovation
CRISPR Therapeutics AG recently filed to sell $600 million in common shares, aiming to strengthen its financial position while analysts…
Stay Updated with Our Newsletter
Get the latest news and insights delivered straight to your inbox.